NYU Cancer Institute - Bellevue Hospital — New York, New York

NYU Cancer Institute - Bellevue Hospital is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Cancer Institute - Bellevue Hospital has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Cancer Institute - Bellevue Hospital?

NYU Cancer Institute - Bellevue Hospital has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Cancer Institute - Bellevue Hospital conducted?

NYU Cancer Institute - Bellevue Hospital has 1 clinical trials on record. Their work covers Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme.

Is NYU Cancer Institute - Bellevue Hospital accredited by Crixeo Health?

NYU Cancer Institute - Bellevue Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Cancer Institute - Bellevue Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.